Symrise completed the acquisition of the remaining shares in Probi for SEK1.2bn.

Symrise, a global supplier of fragrances, flavors, cosmetic active ingredients, and functional ingredients, completed the acquisition of the remaining shares in Probi, a global biotics solutions company, for SEK1.2bn. "We are excited to present this opportunity for shareholders of Probi to realize their investment at an attractive valuation. Symrise has been a long-term shareholder in Probi and has acted with a long-term perspective in the best interests of the Company, its employees and shareholders. Today's offer to Probi’s shareholders reflects Symrise's conviction that Probi would see its prospects enhanced in a private environment. Symrise’s offer comes at an attractive premium and provides Probi’s shareholders with the opportunity to receive their consideration in cash in a timely manner. We are pleased to see that the Offer has received the full support from Probi’s two other largest shareholders – Fjärde AP-fonden and Moneta Asset Management. As a global leader in products supporting health, Symrise is ideally placed to leverage and capitalise on the strong foundation the Probi team has built. By joining forces, we will further strengthen our respective capabilities to serve the market with leading customised solutions, unlocking even greater value for customers globally," Jean-Yves Parisot, Symrise CEO.